Table 2 Affected Relatives and Proband Pc and Ps, The Faroe Islands.

From: Inheritance of Susceptibility to Malignant Blood Disorders

Affected Relatives (mean)/Pc

Affected Relatives Total (males, females) in Ps groups

 

m/m

f/m

m/f

f/f

 

Psm-PA

Psm-MA

Psf-PA

Psf-MA

Totals

LPD/HL

5.7

4.4

9.7

7.6

OBS

65(37, 28)

25(13, 12)

13(6, 7)

18(12, 6)

121(68, 53)

EXP

30(17, 13)

30(17, 13)

30(17, 13)

30(17, 13)

121(68, 53)

OBS/EXP (P)

3(3, 3)

0(0, 0)

−2(−2, 0)

−1(0, 0)

 

LPD/NHL FL

4.9

2.2

8.8

4.0

OBS

13(12, 1)

19(12, 7)

7(2, 5)

25(18, 7)

64(44, 20)

EXP

16(11, 5)

16(11, 5)

16(11, 5)

16(11, 5)

64(44, 20)

OBS/EXP (P)

0(0, 0)

0(0, 0)

−1(−2, 0)

0(0, 0)

 

LPD/NHL DLBCL

4.7

3.9

7.6

6.3

OBS

59(32, 27)

42(23, 19)

39(24, 15)

41(20, 21)

181(99, 82)

EXP

45(25, 20)

45(25, 20)

45(25, 20)

45(25, 20)

181(99, 82)

OBS/EXP (P)

1(0, 0)

0(0, 0)

0(0, 0)

0(0, 0)

 

LPD/NHL NOS

5.9

3.7

7.5

4.7

OBS

28(19, 9)

37(22, 15)

39(23, 16)

30(18, 12)

134(82, 52)

EXP

34(21, 13)

34(21, 13)

34(21, 13)

34(21, 13)

134(82, 52)

OBS/EXP (P)

0(0, 0)

0(0, 0)

0(0, 0)

0(0, 0)

 

LPD/MM

5.8

4.3

9.5

7.0

OBS

102(63, 39)

88(46, 42)

46(23, 23)

77(48, 29)

313(180, 133)

EXP

78(45, 33)

78(45, 33)

78(45, 33)

78(45, 33)

313(180, 133)

OBS/EXP (P)

2(2, 0)

0(0, 0)

−3(−3, 0)

0(0, 0)

 

LPD/CLL

5.0

3.2

7.0

4.5

OBS

82(53, 29)

77(51, 26)

43(19, 24)

38(23, 15)

240(146, 94)

EXP

60(37, 23)

60(37, 23)

60(37, 23)

60(37, 23)

240(146, 94)

OBS/EXP (P)

2(2, 0)

1(1, 0)

−1(−2, 0)

−2(−1, 0)

 

MM/CLL

(Small sample size)

 

OBS

21(14, 7)

17(10, 7)

13(9, 4)

4(4, 0)

55(37, 18)

EXP

14(9, 5)

14(9, 5)

14(9, 5)

14(9, 5)

55(37, 18)

CLL/CLL

(Small sample size)

 

OBS

15(10, 5)

14(7, 7)

12(9, 3)

10(4, 6)

51(30, 21)

EXP

13(8, 5)

13(8, 5)

13(8, 5)

13(8, 5)

51(30, 21)

LPD/ALL

3.5

1.6

5.8

2.7

OBS

19(15, 4)

10(6, 4)

7(3, 4)

15(11, 4)

51(35, 16)

EXP

13(9, 4)

13(9, 4)

13(9, 4)

13(9, 4)

51(35, 16)

OBS/EXP (P)

0(0, 0)

0(0, 0)

0(−1, 0)

0(0, 0)

 

LPD/other LPD

(Small sample size)

 

OBS

11(8, 3)

4(2, 2)

25(9, 16)

12(5, 7)

52(24, 28)

EXP

13(6, 7)

13(6, 7)

13(6, 7)

13(6, 7)

52(24, 28)

LPD/LPD

5.2

3.6

7.7

5.4

OBS

382(239, 143)

299(175, 124)

219(111, 108)

256(153, 103)

1156(678, 478)

EXP

289(170, 119)

289(170, 119)

289(170, 119)

289(170, 119)

1156(678, 478)

OBS/EXP (P)

3(3, 1)

0(0, 0)

−3(−3, 0)

0(0, 0)

 

MPD/LPD

4.0

2.7

5.9

4.0

OBS

85(60, 25)

64(40, 24)

25(7, 18)

63(34, 29)

237(141, 96)

EXP

59(34, 24)

59(34, 24)

59(34, 24)

59(34, 24)

237(141, 96)

OBS/EXP (P)

3(3, 0)

0(0, 0)

−3(−3, 0)

0(0, 0)

 

LPD/MPD

3.2

2.4

4.7

3.6

OBS

91(54, 37)

79(44, 35)

50(21, 29)

71(45, 26)

291(164, 127)

EXP

73(41, 32)

73(41, 32)

73(41, 32)

73(41, 32)

291(164, 127)

OBS/EXP (P)

1(1, 0)

0(0, 0)

−2(−2, 0)

0(0, 0)

 

MPD/MPD

2.8

1.7

4.2

2.5

OBS

95(66, 29)

66(45, 21)

28(10, 18)

47(27, 20)

236(148, 88)

EXP

59(37, 22)

59(37, 22)

59(37, 22)

59(37, 22)

236(148, 88)

OBS/EXP (P)

3(3, 0)

0(0, 0)

−3(−3, 0)

0(0, 0)

 

MPD/AML

2.5

1.7

4.4

3.0

OBS

41(27, 14)

32(19, 13)

17(7, 10)

28(17, 11)

118(70, 48)

EXP

30(18, 12)

30(18, 12)

30(18, 12)

30(18, 12)

118(70, 48)

OBS/EXP (P)

1(1, 0)

0(0, 0)

−1(−2, 0)

0(0, 0)

 

MPD/CML

3.4

2.4

6.2

4.4

OBS

21(15, 6)

12(9, 3)

8(1, 7)

12(6, 6)

53(31, 22)

EXP

13(8, 5)

13(8, 5)

13(8, 5)

13(8, 5)

53(31, 22)

OBS/EXP (P)

1(1, 0)

0(0, 0)

0(−1, 0)

0(0, 0)

 

MPD/other MPD

3.1

1.1

3.4

1.2

OBS

26(19, 7)

16(13, 3)

2(0, 2)

2(2, 0)

46(34, 12)

EXP

12(9, 3)

12(9, 3)

12(9, 3)

12(9, 3)

46(34, 12)

OBS/EXP (P)

3(3, 1)

0(0, 0)

−2(−2, 0)

−2(−1, 0)

 
  1. Comments: Abbreviations, cf. Tables 1 and 2. m, males; f, females.
  2. OBS/EXP (P): observed versus expected (P, chi-squared test).
  3. Zero: observed not different from expected (P > 0.05).
  4. Positive values, observed higher than expected.
  5. Negative values, observed lower than expected.
  6. At the following levels: P < 0.05 score 1, P < 0.01 score 2 and P < 0.001 score 3.